Caveney Brian J 4

4 · LABCORP HOLDINGS INC. · Filed Feb 10, 2026

AI-generated summary of this filing

Updated Feb 10, 2026

Labcorp (LH) EVP Brian Caveney Receives RSUs; Shares Withheld

What Happened

Brian J. Caveney, EVP and President of ED (also CMO & CSO) at Labcorp Holdings (LH), had restricted stock units (RSUs) convert to common shares on Feb 6–7, 2026. A total of 1,298 RSUs vested/converted into shares. To satisfy tax obligations, 389 of those shares were withheld (disposed) in stock withholding transactions, totaling about $107,256. After withholding, Caveney received a net ~909 shares.
These were vesting/conversion events (derivative/RSU transactions), not open-market buys or sales. The withholding is a routine tax-payment method, not a discretionary sale.

Key Details

Transaction dates: RSU conversion on 2026-02-06 (670 shares) and 2026-02-07 (517 + 111 shares); tax-withholding/stock surrender on 2026-02-06 (209 shares at $277.20 = $57,935) and 2026-02-09 (148 + 32 shares at $274.01 = $49,321; combined = $40,553 + $8,768 = $49,321). Total withheld value ≈ $107,256.
Net shares issued to insider after withholding: ~909 shares (1,298 converted − 389 withheld).
Footnotes: F1 = each RSU converts to one share; F3 = stock withholding used to satisfy tax obligations; F4/F6 = vesting schedules (these RSUs vested per grant terms).
Filing: Form filed Feb 10, 2026 reporting transactions through Feb 6–9, 2026. (The filing shows the conversion and withholding events; it does not represent an open-market sale or a discretionary purchase.)

Context

This was a vesting/conversion of restricted stock units with shares surrendered to cover taxes (a cashless/withholding routine). Such withholding transactions are administrative and common when equity awards vest and typically do not signal the insider taking a market view for buying/selling.

Form 4

Period: 2026-02-06

EVP, Pres of ED, CMO & CSO

Transactions

Exercise/Conversion
Common Stock
[F1][F2]
2026-02-06+670→ 30,838.923 total
Tax Payment
Common Stock
[F3]
2026-02-06$277.20/sh−209$57,935→ 30,629.923 total
Exercise/Conversion
Common Stock
[F1]
2026-02-07+517→ 31,146.923 total
Exercise/Conversion
Common Stock
[F1]
2026-02-07+111→ 31,257.923 total
Tax Payment
Common Stock
[F3]
2026-02-09$274.01/sh−148$40,553→ 31,109.923 total
Tax Payment
Common Stock
[F3]
2026-02-09$274.01/sh−32$8,768→ 31,077.923 total
Exercise/Conversion
Restricted Stock Unit
[F1][F4][F5]
2026-02-06−670→ 3,518 total
→ Common Stock (670 underlying)
Exercise/Conversion
Restricted Stock Unit
[F1][F6][F5]
2026-02-07−517→ 3,001 total
→ Common Stock (517 underlying)
Exercise/Conversion
Restricted Stock Unit
[F1][F6][F5]
2026-02-07−111→ 2,890 total
→ Common Stock (111 underlying)

Footnotes (6)

[F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[F2]Amount includes 57.1306 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan and 45.1355 shares acquired on December 31, 2025 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan.
[F3]Stock withholding to satisfy tax withholding obligations.
[F4]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
[F5]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
[F6]The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.

Signature

/s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney|2026-02-10

2 files